Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gleitz HFE"'
Autor:
Fuchs SNR; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Stalmann USA; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Snoeren IAM; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Bindels E; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Schmitz S; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Banjanin B; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Hoogenboezem RM; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van Herk S; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Saad M; Department of Cell and Tumor Biology, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany., Walter W; MLL Munich Leukemia Laboratory, Munich, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Seillier L; Cancer Research Center Cologne Essen, University Hospital Cologne, Cologne, Germany.; Joint Research Center for Computational Biomedicine, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany., Saez-Rodriguez J; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany., Dugourd AJF; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany., Lehmann KV; Cancer Research Center Cologne Essen, University Hospital Cologne, Cologne, Germany.; Joint Research Center for Computational Biomedicine, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany., Ben-Neriah Y; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel., Gleitz HFE; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Schneider RK; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Department of Cell and Tumor Biology, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 766-779.
Autor:
Pritchard JE; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Pearce JE; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Snoeren IAM; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Fuchs SNR; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Götz K; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Peisker F; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University Hospital, Aachen, Germany., Wagner S; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Benabid A; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Lutterbach N; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Klöker V; Institute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany., Nagai JS; Institute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany., Hannani MT; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University Hospital, Aachen, Germany; Institute for Computational Biomedicine, Heidelberg University Hospital, Heidelberg, Germany., Galyga AK; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Sistemich E; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Banjanin B; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Flosdorf N; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany., Bindels E; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands., Olschok K; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Biaesch K; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Chatain N; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Bhagwat N; Prelude Therapeutics, Wilmington, DE, USA., Dunbar A; Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sarkis R; Laboratory of Regenerative Hematopoiesis, Department of Biomedical Sciences (DSB), Université de Lausanne (UNIL), Lausanne, Switzerland., Naveiras O; Laboratory of Regenerative Hematopoiesis, Department of Biomedical Sciences (DSB), Université de Lausanne (UNIL), Lausanne, Switzerland., Berres ML; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Medical Department III, RWTH University Hospital Aachen, Aachen, Germany., Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Levine RL; Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Costa IG; Institute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany., Gleitz HFE; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Kramann R; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University Hospital, Aachen, Germany; Department of Internal Medicine, Nephrology and Transplantation, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Aachen, Germany., Schneider RK; Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: reschneider@ukaachen.de.
Publikováno v:
Cell reports [Cell Rep] 2024 Jan 23; Vol. 43 (1), pp. 113608. Date of Electronic Publication: 2023 Dec 20.
Autor:
Ellison S; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Liao A; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Gleitz HFE; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Parker H; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Booth L; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Robinson J; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Wood S; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Taylor J; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Holley R; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK., Bigger BW; Stem Cell & Neurotherapies Group, University of Manchester, Manchester M13 9PT, UK.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Oct 20; Vol. 31, pp. 101127. Date of Electronic Publication: 2023 Oct 20 (Print Publication: 2023).
Autor:
Gleitz HFE; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam., Schneider RK; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cell Biology, Faculty of Medicine, Institute for Biomedical Engineering, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen. reschneider@ukaachen.de.
Publikováno v:
Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1203-1204. Date of Electronic Publication: 2023 May 01.
Autor:
Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. john.mascarenhas@mssm.edu., Gleitz HFE; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Chifotides HT; Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Harrison CN; Guy's and St Thomas' NHS Foundation Trust, London, UK., Verstovsek S; Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vannucchi AM; Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Rampal RK; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Kiladjian JJ; Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Vainchenker W; Gustave Roussy, INSERM UMR1287, Université Paris-Saclay, Villejuif, France., Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Schneider RK; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Institute of Cell and Tumor Biology, RWTH Aachen University, Medical Faculty, Aachen, Germany., List AF; Precision BioSciences, Inc, Durham, NC, USA.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 255-264. Date of Electronic Publication: 2022 Nov 24.
Autor:
Stalmann USA; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Ticconi F; Institute for Computational Genomics, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany., Snoeren IAM; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Li R; Institute for Computational Genomics, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany., Gleitz HFE; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Cowley GS; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA., McConkey ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wong AB; Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands., Schmitz S; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Fuchs SNR; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Sood S; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM GMBH), Heidelberg, Germany., Leimkühler NB; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Martinez-Høyer S; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Banjanin B; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Root D; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA., Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation., Pearce JE; Department of Cell Biology, Institute for Biomedical Engineering, Faculty of Medicine, and., Schuppert A; Joint Research Center for Computational Biomedicine, RWTH Aachen University, Aachen, Germany., Bindels EMJ; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Essers MA; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM GMBH), Heidelberg, Germany., Heckl D; Pediatric Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany., Stiehl T; Institute for Computational Biomedicine-Disease Modeling, Faculty of Medicine, RWTH Aachen University, Aachen, Germany; and., Costa IG; Institute for Computational Genomics, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Howard Hughes Medical Institute, Boston, MA., Schneider RK; Department of Developmental Biology and.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Cell Biology, Institute for Biomedical Engineering, Faculty of Medicine, and.
Publikováno v:
Blood advances [Blood Adv] 2022 Mar 22; Vol. 6 (6), pp. 1780-1796.
Autor:
Gleitz HFE; Department of Developmental Biology.; Oncode Institute, Erasmus MC, Rotterdam, The Netherlands., Benabid A; Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University, Aachen, Germany., Schneider RK; Department of Developmental Biology.; Oncode Institute, Erasmus MC, Rotterdam, The Netherlands.; Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University, Aachen, Germany.
Publikováno v:
Current opinion in hematology [Curr Opin Hematol] 2021 Sep 01; Vol. 28 (5), pp. 364-371.
Autor:
Gleitz HFE; Department of Hematology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Current address: Department of Developmental Biology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Oncode Institute, Erasmus MC, Rotterdam, 3015GD, the Netherlands., Snoeren IAM; Department of Hematology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Current address: Department of Developmental Biology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Oncode Institute, Erasmus MC, Rotterdam, 3015GD, the Netherlands., Fuchs SNR; Department of Hematology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Current address: Department of Developmental Biology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Oncode Institute, Erasmus MC, Rotterdam, 3015GD, the Netherlands., Leimkühler NB; Department of Hematology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Schneider RK; Department of Hematology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Current address: Department of Developmental Biology, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Oncode Institute, Erasmus MC, Rotterdam, 3015GD, the Netherlands.; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany.; Institute for Biomedical Engineering, Department of Cell Biology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
Publikováno v:
STAR protocols [STAR Protoc] 2021 May 12; Vol. 2 (2), pp. 100538. Date of Electronic Publication: 2021 May 12 (Print Publication: 2021).
Autor:
Leimkühler NB; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Gleitz HFE; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Ronghui L; Institute for Computational Genomics, Faculty of Medicine, RWTH Aachen University, Aachen 52074 Germany., Snoeren IAM; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Fuchs SNR; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Nagai JS; Institute for Computational Genomics, Faculty of Medicine, RWTH Aachen University, Aachen 52074 Germany., Banjanin B; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Lam KH; Department of Pathology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Vogl T; Institute of Immunology, University of Münster, Münster 49148, Germany., Kuppe C; Division of Nephrology and Clinical Immunology, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Stalmann USA; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Büsche G; Institute of Pathology, Hannover Medical School, Hannover 30625, Germany., Kreipe H; Institute of Pathology, Hannover Medical School, Hannover 30625, Germany., Gütgemann I; Institute of Pathology, University of Bonn, Bonn 53127, Germany., Krebs P; Institute of Pathology, University of Bern, Bern 3012, Switzerland., Banz Y; Institute of Pathology, University of Bern, Bern 3012, Switzerland., Boor P; Institute of Pathology, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Tai EW; Institute of Pathology, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Crysandt M; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany., Bindels E; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands., Kramann R; Division of Nephrology and Clinical Immunology, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen 52074, Germany., Costa IG; Institute for Computational Genomics, Faculty of Medicine, RWTH Aachen University, Aachen 52074 Germany., Schneider RK; Department of Hematology, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands; Department of Cell Biology, Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany; Oncode Institute, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands. Electronic address: reschneider@ukaachen.de.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2021 Apr 01; Vol. 28 (4), pp. 637-652.e8. Date of Electronic Publication: 2020 Dec 09.
Autor:
Gleitz HFE; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Dugourd AJF; Joint Research Centre for Computational Biomedicine, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.; Institute of Computational Biomedicine, Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Heidelberg, Germany., Leimkühler NB; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Snoeren IAM; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Fuchs SNR; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Menzel S; Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany., Ziegler S; Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Triviai I; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Büsche G; Institute of Pathology, Hannover Medical School, Hannover, Germany., Kreipe H; Institute of Pathology, Hannover Medical School, Hannover, Germany., Banjanin B; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Pritchard JE; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Hoogenboezem R; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Bindels EM; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Schumacher N; Institute of Biochemistry, University of Kiel, Kiel, Germany., Rose-John S; Institute of Biochemistry, University of Kiel, Kiel, Germany., Elf S; Ben May Department, University of Chicago, Chicago, IL., Saez-Rodriguez J; Joint Research Centre for Computational Biomedicine, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.; Institute of Computational Biomedicine, Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Heidelberg, Germany., Kramann R; Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.; Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands., Schneider RK; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany; and.; Institute for Biomedical Engineering, Department of Cell Biology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
Publikováno v:
Blood [Blood] 2020 Oct 29; Vol. 136 (18), pp. 2051-2064.